Clin2
NCT07136727Likely a fitNot yet recruiting

AI health management for cancer patients with other illnesses

Oncological Comorbidities (e. g. Hypertension, Diabetes, Malnutrition)

Part of Cancer, Hormones & metabolism clinical trials.

This study tests an AI-powered program that helps doctors manage cancer patients who also have other health conditions. You may be able to join if you are starting or currently receiving cancer treatment and can use a smart device.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
5,000 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a confirmed cancer diagnosis from a biopsy or cell test.
  • You are at least 18 years old.
  • You plan to start cancer treatment within 2 weeks, or are already getting surgery, radiation, chemo, or targeted therapy.
  • You are alert and able to use a smartphone or tablet on your own to answer questions.
  • You do not have a serious mental condition or life-threatening illness like severe heart failure or kidney failure.
  • You are not pregnant or breastfeeding.
  • You have not taken part in another research study in the past month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06791473Recruiting
AI cancer diagnosis study using electronic health records

This study uses artificial intelligence to analyze electronic health records (including medical history, lab results, and imaging data) to improve cancer diagnosis and prediction. It aims to help identify cancer earlier and more accurately, potentially leading to better treatment outcomes.

Guangzhou, Guangdong
NCT07198581Recruiting
Using AI to manage chemotherapy side effects

This trial tests if an AI-powered system can help monitor and manage side effects during chemotherapy for breast or colorectal cancer. If you are starting chemotherapy and can report your symptoms, this study may offer extra support.

Incheon
NCT05196087Recruiting
AI system to monitor cancer treatment progress

This trial tests a non-invasive, AI-based monitoring program for people with solid tumors. It aims to help track how you’re doing during or after curative-intent treatment, using information collected without extra procedures.

Toronto, Ontario
NCT07396142Not yet recruiting
AI companion for cancer patients and caregivers

This trial tests an AI-powered companion (BaiXiaoAi) on WeChat to help cancer patients and their caregivers manage follow-up care. If you have a cancer diagnosis, are 18 or older, and can use WeChat in Chinese, you may be able to join.

NCT07409298Enrolling by invitation
AI support for breast cancer patients on CDK4/6 inhibitors

This trial tests whether an AI-powered management program can improve mental health and daily habits for people with HR+/HER2- breast cancer who are taking CDK4/6 inhibitor pills at home. It is designed to help you feel supported and stay on track with your rehabilitation plan.

Tianjin
NCT06415201Recruiting
AI mental health support for cancer patients

This study is testing an interactive AI-based service to support the mental health of people with cancer. It is designed to help during or after cancer treatment.

Seoul, Seoul

Hear when a new Oncological Comorbidities (e. g. Hypertension, Diabetes, Malnutrition) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.